Healthcare & Life Sciences News and Articles

Google News – Pharmaceuticals External News

Tonix Pharma (NASDAQ: TNXP) CEO adds 2,000 shares in IRA - Stock Titan

news.google.com · 31 Aug 2026

Google News – Pharmaceuticals External News

Veloxis Pharmaceuticals Doses First Patient in RENGEVITY-201 Phase 2 Trial of Pegrizeprument for the Prevention of Organ Rejection in Kidney Transplant Recipients - PR Newswire

news.google.com · 31 Aug 2026

Google News – Biopharma External News

RedHill Biopharma (RDHL) Completes Talicia Sale Amid Challenging Valuation Landscape - GuruFocus

news.google.com · 31 Aug 2026

Google News – FDA (biotech/pharma) External News

Cronus Pharma Launches FDA-Approved Robenacoxib Injection for Veterinary Use - Machine Maker

news.google.com · 31 Aug 2026

Google News – Clinical Trials External News

Karyopharm Submits Supplemental New Drug Application to the FDA for XPOVIO® (selinexor) Plus Ruxolitinib for Patients with Myelofibrosis - Karyopharm

news.google.com · 31 Aug 2026

Google News – Biopharma External News

Is Biohaven (BHVN) A Bargain On Its SK Biopharma Licensing Deal? - simplywall.st

news.google.com · 31 Aug 2026

Google News – Clinical Trials External News

Palvella Therapeutics Completes Rolling Submission of New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations - The Malone Telegram

news.google.com · 31 Aug 2026

Google News – Pharmaceuticals External News

Quoin Pharmaceuticals Raises Up To $50 Million As Financing Could Extend Runway Into Second Half Of 2029 - Pulse 2.0

news.google.com · 31 Aug 2026

Google News – Biopharma External News

RedHill Biopharma (RDHL) sells Talicia stake for upfront pay, milestone upside - Stock Titan

news.google.com · 31 Aug 2026

Google News – Biopharma External News

Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21 - Business Wire

news.google.com · 31 Aug 2026

Google News – Biopharma External News

Jefferies starts biopharma firm Braveheart at Buy after IPO By Investing.com - Investing.com India

news.google.com · 31 Aug 2026

Google News – Pharmaceuticals External News

Teva Pharmaceuticals to acquire BioXcel assets for up to $125m - finance.yahoo.com

news.google.com · 31 Aug 2026

Google News – Pharmaceuticals External News

Teva Pharmaceuticals to acquire BioXcel assets for up to $125m - finance.yahoo.com

news.google.com · 31 Aug 2026

Google News – Digital Health External News

CHARAKA, Telemedicine Society of India Sign MoU to Strengthen Digital Health & Telemedicine - Digital Health News

news.google.com · 31 Aug 2026

Google News – FDA (biotech/pharma) External News

Jemperli accepted for priority review by US FDA - PharmaTimes

news.google.com · 31 Aug 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

Tonix Pharma (NASDAQ: TNXP) CEO adds 2,000 shares in IRA - Stock Titan

Veloxis Pharmaceuticals Doses First Patient in RENGEVITY-201 Phase 2 Trial of Pegrizeprument for the Prevention of Organ Rejection in Kidney Transplant Recipients - PR Newswire

RedHill Biopharma (RDHL) Completes Talicia Sale Amid Challenging Valuation Landscape - GuruFocus

Cronus Pharma Launches FDA-Approved Robenacoxib Injection for Veterinary Use - Machine Maker

Karyopharm Submits Supplemental New Drug Application to the FDA for XPOVIO® (selinexor) Plus Ruxolitinib for Patients with Myelofibrosis - Karyopharm

Is Biohaven (BHVN) A Bargain On Its SK Biopharma Licensing Deal? - simplywall.st

Palvella Therapeutics Completes Rolling Submission of New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations - The Malone Telegram

Quoin Pharmaceuticals Raises Up To $50 Million As Financing Could Extend Runway Into Second Half Of 2029 - Pulse 2.0

RedHill Biopharma (RDHL) sells Talicia stake for upfront pay, milestone upside - Stock Titan

Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21 - Business Wire

Jefferies starts biopharma firm Braveheart at Buy after IPO By Investing.com - Investing.com India

Teva Pharmaceuticals to acquire BioXcel assets for up to $125m - finance.yahoo.com

Teva Pharmaceuticals to acquire BioXcel assets for up to $125m - finance.yahoo.com

CHARAKA, Telemedicine Society of India Sign MoU to Strengthen Digital Health & Telemedicine - Digital Health News

Jemperli accepted for priority review by US FDA - PharmaTimes